Atomic AI
South San Francisco
About Atomic AI
Atomic AI combines machine learning with structural biology to enable the design of RNA-targeted small molecules and RNA-based therapeutics. Its proprietary R&D platform integrates deep learning foundation models with specialized in-house wet-lab assays to support iterative discovery and refinement. A key component of the platform is ATOM-1™, a large language model trained on chemical mapping data to predict RNA structure and function more accurately.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $42.0M
- Funding stage: Early Stage Venture
- Last round: Series A (Aug 2023)
- Website: atomic.ai
- Phone: [email protected]
Industries & Categories
Artificial Intelligence (AI), Machine Learning, Medical
Social Profiles
Canonical: https://fsome.com/organization/atomic-ai-113688 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.